Large-scale simulations of H and He reionization and heating driven by stars and more energetic sources

We present simulations of cosmic reionization and reheating from z = 18 to z = 5, investigating the role of stars (emitting soft UV-photons), nuclear black holes (BHs, with power-law spectra), X-ray binaries (XRBs, with hard X-ray dominated spectra), and the supernova-associated thermal bremsstrahlung of the diffuse interstellar medium (ISM, with soft X-ray spectra). We post-process the hydrodynamical simulation MassiveBlack-II (MBII) with multifrequency ionizing radiative transfer. The source properties are directly derived from the physical environment of MBII, and our only real free parameter is the ionizing escape fraction fesc. We find that, among the models explored here, the one with an escape fraction that decreases with decreasing redshift yields results most in line with observations, such as of the neutral hydrogen fraction and the Thomson scattering optical depth. Stars are the main driver of hydrogen reionization and consequently of the thermal history of the intergalactic medium (IGM). We obtain = 0.99998 at z = 6 for all source types, with volume-averaged temperatures < T > ∼ 20 000 K. BHs are rare and negligible to hydrogen reionization, but conversely they are the only sources that can fully ionize helium, increasing local temperatures by ∼104 K. The thermal and ionization state of the neutral and lowly ionized hydrogen differs significantly with different source combinations, with ISM and (to a lesser extent) XRBs, playing a significant role and, as a consequence, determining the transition from absorption to emission of the 21-cm signal from neutral hydrogen

The Leeway of Shipping Containers at Different Immersion Levels

The leeway of 20-foot containers in typical distress conditions is established through field experiments in a Norwegian fjord and in open-ocean conditions off the coast of France with wind speed ranging from calm to 14 m/s. The experimental setup is described in detail and certain recommendations given for experiments on objects of this size. The results are compared with the leeway of a scaled-down container before the full set of measured leeway characteristics are compared with a semi-analytical model of immersed containers. Our results are broadly consistent with the semi-analytical model, but the model is found to be sensitive to choice of drag coefficient and makes no estimate of the cross-wind leeway of containers. We extend the results from the semi-analytical immersion model by extrapolating the observed leeway divergence and estimates of the experimental uncertainty to various realistic immersion levels. The sensitivity of these leeway estimates at different immersion levels are tested using a stochastic trajectory model. Search areas are found to be sensitive to the exact immersion levels, the choice of drag coefficient and somewhat less sensitive to the inclusion of leeway divergence. We further compare the search areas thus found with a range of trajectories estimated using the semi-analytical model with only perturbations to the immersion level. We find that the search areas calculated without estimates of crosswind leeway and its uncertainty will grossly underestimate the rate of expansion of the search areas. We recommend that stochastic trajectory models of container drift should account for these uncertainties by generating search areas for different immersion levels and with the uncertainties in crosswind and downwind leeway reported from our field experiments.Comment: 25 pages, 11 figures and 5 tables; Ocean Dynamics, Special Issue on Advances in Search and Rescue at Sea (2012

How to build a robust provider improvement partnership program to enhance patient experience – A case study

Patient experience is emerging as a key differentiating factor in patients’ choice of healthcare system. Many healthcare organizations are attempting to improve their patient experience by data-driven, patient-centered initiatives. This involves engaging all staff along all the contact points of a patient’s journey in healthcare. Perhaps, the physicians or care providers are most important link in this chain but also the most challenging to engage in improvement efforts. Most healthcare organizations have some training or workshops to educate providers on communication skills and other tools to enhance patient experience. However, there seems to a paucity of a standardized approach or a roadmap to put together a robust physician or care provider coaching or improvement partnership program with patient experience (PX) staff. There seems to be several gaps in this process. The current article attempts to develop broad guidelines and suggest a roadmap to address these gaps. The article also suggests general templates for PX staff to use in conducting these improvement work with providers and suggestions for developing a standard physician observation or shadowing template for consistency. The article has woven several commonly used tools like motivational interviewing, change management (ADKAR model), and several communication tools to suggest a detailed blue print for provider patient experience improvement partnership

Gestational age at delivery and special educational need: retrospective cohort study of 407,503 schoolchildren

<STRONG>Background</STRONG> Previous studies have demonstrated an association between preterm delivery and increased risk of special educational need (SEN). The aim of our study was to examine the risk of SEN across the full range of gestation. <STRONG>Methods and Findings</STRONG> We conducted a population-based, retrospective study by linking school census data on the 407,503 eligible school-aged children resident in 19 Scottish Local Authority areas (total population 3.8 million) to their routine birth data. SEN was recorded in 17,784 (4.9%) children; 1,565 (8.4%) of those born preterm and 16,219 (4.7%) of those born at term. The risk of SEN increased across the whole range of gestation from 40 to 24 wk: 37–39 wk adjusted odds ratio (OR) 1.16, 95% confidence interval (CI) 1.12–1.20; 33–36 wk adjusted OR 1.53, 95% CI 1.43–1.63; 28–32 wk adjusted OR 2.66, 95% CI 2.38–2.97; 24–27 wk adjusted OR 6.92, 95% CI 5.58–8.58. There was no interaction between elective versus spontaneous delivery. Overall, gestation at delivery accounted for 10% of the adjusted population attributable fraction of SEN. Because of their high frequency, early term deliveries (37–39 wk) accounted for 5.5% of cases of SEN compared with preterm deliveries (<37 wk), which accounted for only 3.6% of cases. <STRONG>Conclusions</STRONG> Gestation at delivery had a strong, dose-dependent relationship with SEN that was apparent across the whole range of gestation. Because early term delivery is more common than preterm delivery, the former accounts for a higher percentage of SEN cases. Our findings have important implications for clinical practice in relation to the timing of elective delivery

Human-machine networks: Towards a typology and profiling framework

© Springer International Publishing Switzerland 2016. In this paper we outline an initial typology and framework for the purpose of profiling human-machine networks, that is, collective structures where humans and machines interact to produce synergistic effects. Profiling a humanmachine network along the dimensions of the typology is intended to facilitate access to relevant design knowledge and experience. In this way the profiling of an envisioned or existing human-machine network will both facilitate relevant design discussions and, more importantly, serve to identify the network type. We present experiences and results from two case trials: a crisis management system and a peerto- peer reselling network. Based on the lessons learnt from the case trials we suggest potential benefits and challenges, and point out needed future work

Mitigating Systems Performance Index Baselines

This paper discusses the technical assessment of recommended train unavailability and component unreliability baselines for the US Nuclear Regulatory Commission Mitigating Systems Performance Index. To perform this evaluation, recent data were compared with the recommended baselines. Comparisons indicate that the recommended baselines appear to accurately represent recent (1999 – 2001) industry experience

Toxocaríase humana: incidência de infecção em indivíduos residentes na periferia de Campinas, Estado de São Paulo, Brasil

With the aim of estimating the incidence of infection by Toxocara among residents in the outskirts of Campinas (State of São Paulo, Brazil) two serological surveys, using ELISA anti-Toxocara tests, were performed in January 1999 and January 2000, involving, respectively, 138 and 115 individuals, 75 of which examined in both occasions. Among this group 67 individuals did not show the presence of anti-Toxocara antibodies in 1999, and 12 presented seroconversion in the second survey, revealing an annual incidence rate of 17.9%.Dois inquéritos sorológicos empregando testes imunoenzimáticos (ELISA) anti-Toxocara foram realizados em moradores da periferia de Campinas (SP, Brasil) em janeiro de 1999 e janeiro de 2000, envolvendo, respectivamente, 138 e 115 indivíduos escolhidos aleatoriamente. Dos 75 indivíduos examinados em ambas as ocasiões, 67 apresentaram resultados negativos em 1999, observando-se soroconversão em 12 no segundo inquérito. Tais resultados indicam taxa anual de incidência de 17,9% para infecção por Toxocara na região

IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in jak2v617f-positive myeloproliferative neoplasms

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)The recurrent V617F mutation in JAK2 (JAK2(V617F)) has emerged as the primary contributor to the pathogenesis of myeloproliferative neoplasms (MPN). However, the lack of complete response in most patients treated with the JAK1/2 inhibitor, ruxolitinib, indicates the need for identifying pathways that cooperate with JAK2. Activated JAK2 was found to be associated with the insulin receptor substrate 2 (IRS2) in non-hematological cells. We identified JAK2/IRS2 binding in JAK2(V617F) HEL cells, but not in the JAK2(WT) U937 cell line. In HEL cells, IRS2 silencing decreased STAT5 phosphorylation, reduced cell viability and increased apoptosis; these effects were enhanced when IRS2 silencing was combined with ruxolitinib. In U937 cells, IRS2 silencing neither reduced cell viability nor induced apoptosis. IRS1/2 pharmacological inhibition in primary MPN samples reduced cell viability in JAK2(V617F)-positive but not JAK2(WT) specimens; combination with ruxolitinib had additive effects. IRS2 expression was significantly higher in CD34(+) cells from essential thrombocythemia patients compared to healthy donors, and in JAK2(V617F) MPN patients when compared to JAK2(WT). Our data indicate that IRS2 is a binding partner of JAK2(V617F) in MPN. IRS2 contributes to increased cell viability and reduced apoptosis in JAK2-mutated cells. Combined pharmacological inhibition of IRS2 and JAK2 may have a potential clinical application in MPN.The recurrent V617F mutation in JAK2 (JAK2V617F) has emerged as the primary contributor to the pathogenesis of myeloproliferative neoplasms (MPN). However, the lack of complete response in most patients treated with the JAK1/2 inhibitor, ruxolitinib, indi7669486959sem informaçãoConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)sem informaçã